| Literature DB >> 36060625 |
Cesar Miguel Momesso Santos1,2, Jônatas Bussador Amaral3, Marcelo Rossi3, Rodolfo Paula Vieria4,5,6,7, Cesar Cavinato Cal Abad8,9, André Luis Lacerda Bachi3,10.
Abstract
Purpose: To investigate the effects of triathlon racing under extreme conditions on metabolic and immune/inflammatory responses.Entities:
Keywords: cycling; cytokines; exercise immunology; exercise physiology; strenuous exercise
Year: 2022 PMID: 36060625 PMCID: PMC9429993 DOI: 10.3389/fspor.2022.915343
Source DB: PubMed Journal: Front Sports Act Living ISSN: 2624-9367
Figure 1Flow diagram and experimental design of the study.
Data related to anthropometric, metabolic, and performance characteristics of the athlete volunteers in the study.
|
|
|
|---|---|
| Cycling test | |
| VT1 (ml.kg.min−1) | 37.80 (± 4.60) |
| VT1 (%VO2max) | 70.20 (± 4.10) |
| VT2 (ml.kg.min−1) | 47.50 (± 6.30) |
| VT2 (%VO2max) | 88.00 (± 4.70) |
| VO2max (ml.kg.min−1) | 53.91 (± 7.87) |
| Maximum load (W) | 374.62 (± 59.11 |
| Running test | |
| VT1 (ml.kg.min−1) | 44.80 (± 5.10) |
| VT1 (%VO2max) | 82.20 (± 7.60) |
| VT2 (ml.kg.min−1) | 51.30 (± 7.10) |
| VT2 (%VO2max) | 93.50 (± 3.00) |
| VO2max (ml.kg.min−1) | 54.64 (± 8.48) |
| Maximum load (km.h−1) | 17.45 (± 1.52) |
| Racing performance | |
| Swimming time (hh:mm:ss) | 01:10:55 (± 00:10:05) |
| Cycling time (hh:mm:ss) | 09:29:37 (± 01:14:36) |
| Running time (hh:mm:ss) | 05:05:00 (± 00:56:34) |
| Total race time (hh:mm:ss) | 15:45:32 (± 02:06:44) |
VT1, first ventilatory threshold; VT2, second ventilatory threshold; VO2max, maximal oxygen uptake.
Values [mean and standard deviation (SD) of circulating glucose levels, lipid profile (total cholesterol, cholesterol non-HDL, HDL, LDL, and triglycerides, in mg/dL), leukogram (total leukocytes, lymphocytes, monocytes, and granulocytes, in %), and plasma volume (in %) of volunteers in three different time-points: baseline, IM and 12h post-extreme ultra-triathlon race.
|
|
|
| |
|---|---|---|---|
|
|
|
| |
| Circulating Glucose Levels (mg/dL) | 127.4 ± 38.25 | ||
| Lipid profile (mg/dL) | |||
| Total cholesterol | 158.9 ± 11.78 | 165.2 ± 17.56 | 173.9 ± 21.68 |
| Cholesterol non-HDL | 118.1 ± 11.88 | 122.6 ± 16.74 | 132.00 ± 20.80 |
| HDL | 40.78 ± 1.61 | 42.61 ± 2.99 | 41.92 ± 2.03 |
| LDL | 66.12 ± 11.90 | ||
| Triglycerides | 259.9 ± 77.58 | ||
| Leukogram (%) | |||
| Total leukocytes | 6.25 ± 1.45 | ||
| Lymphocytes | 21.91 ± 0.08 | ||
| Monocytes | 12.16 ± 8.55 | 9.94 ± 2.57 | 11.31 ± 2.11 |
| Granulocytes | 64.01 ± 9.93 | ||
| Plasma volume (%) | 100 ± | 108.43 ± 20.63 | 109.59 ± 20.72 |
p < 0.05 in relation to baseline values;
p < 0.05 in relation to IM values. Bold values indicate the statistical differences.
Figure 2(A–G) Levels of plasma cytokines in different time-points: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 3(A–G) Profile of inflammatory and non-inflammatory cytokines at the time-points, in LPS+ and LPS−: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 4(A–C) Pearson's correlation of IL-6 cytokine at the three time-points.